Experimental photodynamic therapyof tumors with 5-ala
N.F. Gamaleia, V.V. Kutsenok, O.B.Gorobets,M.O. Lozinsky, A.N. Borisevich, V.V.Holin.
R.E.Kavetsky Institute for Experimental Pathology, Oncologyand Radiobiology, NAS of Ukraine; Institute of OrganicChemistry, NAS of Ukraine; “Photonics plus”, Ukraine
Abstract
The photodynamic therapy (PDT) of Lewis carcinoma in
с57Вl/6 mice and sarcoma 180 in random bred mice was carried
out with 5-aminolaevulinic acid (ALA) used as a photosensi-
tizer. It has been shown that ALA-PDT effectively inhibited
the growth of Lewis carcinoma and sarcoma 180, decreased
the frequency of metastatic spreading and the number of me-
tastases to lung in mice with Lewis carcinoma. It is concluded
that PDT with ALA is a potentially perspective method of
tumor treatment.
References
- Гамалея Н.Ф., Куценок В.В., Чехун В.Ф. Применении5-аминолевулиновой кислоты в фотодинамическойтерпии и фотодиагностике опухолей // Онкология. –2003. – 5, №3. – С. 239–244.
- Гамалея Н.Ф., Михалкин И.А. Световая терапияопухолей с применением фотосенсибилизаторов //Эксперим. онкология. – 1988. – 10, №1. – С. 9–16.
- Цыб А.Ф., Каплан М.А., Молочков В.А. и др. Оприменении фотодинамической терпии в лечениисолитарных и множественных базалиом //Рос. журн.кожн. и венерол. болезней. – 2000. – 4. – С. 4–12.
- Bagnonas S., Ma L.W., Iani V. et al. Phototransformationsof 5-aminolevulinic acid-induced protoporphyrin IXin vitro: a spectroscopy study // Photochem. Photobiol. –2000. – 72, №2. – Р. 186–192.
- Bonnett R. // Chemical aspects of PDT. – 2000.
- Bugelski PJ, Porter CW, Dougherty TJ. Autoradio-graphic distribution of hematoporphyrin derivative innormal and tumor tissue of the mouse // Cancer Res. –1981. – 41. – С. 4606–4612.
- Gerscher S., Connelly J.P., Griffiths J. et al. Comparisonof the pharmacokinetics and phototoxicity of proto-porphyrin IX metabolized from 5-aminolevulinic acidand two derivatives in human skin in vivo // Photo-chem.Photobiol. – 2000. – 72, №4. –С. 569–574.
- Goldman M., Atkin D. ALA/PDT in the treatment ofactinic keratosis: spot versus confluent therapy //J.Cosmet. Laser Ther. – 2003. – 5, №2. – С. 107–110.
- 9. Hinnen P., de Rooij F.W., Hop W.C. et al. Timing of 5-aminolaevulinic acid-induced photodynamic therapy forthe treatment of patients with Barrett’s oesophagus //J.Photochem. Photobiol. B. – 2002. – 68, №1. – С. 8–14.
- 10. Kennedy JC, Pottier RH. Endogenous protoporphy-rin IX, a clinically useful photosensitizer for photo-dynamic therapy // Ibid. – 1992. – 14. – С. 275–292.
- Kennedy JC, Pottier RH, Pross DC. Photodynamic therapywith endogenous protoporphyrin IX: basic principles andpresent clinical experience // Ibid. – 1991. – 6. – С. 143–148.
- Ketly C.J., Brown N.J., Reed M.W.R., Ackroyd R.The use of 5-aminolaevulinic acid as a photosensi-tizer in photodynamic therapy and photodiagnosis// Photochem. Photobiol. Sci. – 2002. – 1. – С. 158–168.
- Kohen E., Santus R., Hirschberg I.G. Photobiology. – 1995.
- Macdonald LG, Dougherty TJ. Basic principles ofphotodynamic therapy //J. Porphyrins Phthalocya-nines. – 2001. – 5. – С. 105–129.
- Pass H. Photodynamic therapy in oncology: mecha-nisms and clinical use //J.Nat.Cancer Inst. – 1993. –85, №6. – С.443–456.
- Rick K., Sroka R., Stepp H. et al. Pharmacokinetics of5-aminolevulinic acid- induced protoporphyrin IX inskin and blood // J.Photochem.Photobiol. – 1997. –40, №3. – С. 313–319.
- Sorensen R., Iani V., Moan J. Kinetics of photobleachingof protoporphyrin IX in the skin of nude mice ex-posed to different fluence rates of red light // Ibid. –1998. – 68, №6. – С. 835–840.
- Szeimies R.M., Landthaler M. Photodynamic therapyand fluorescence diagnosis of skin cancers //Cancer.Res. – 2002. – 160. – С. 240–245.
- 19. Van den Boogert J., Houstmuller A.B., de Rooij F.W.et al. Kinetics, localization, and mechanism of 5-aminolevulinic acid- induced porphyrin accumula-tion in normal and Barretts-like rat esophagus //Lasers Surg. Med. – 1999. – 24, №1. – С. 3–13.
|